1. Home
  2. TRT vs BCTX Comparison

TRT vs BCTX Comparison

Compare TRT & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trio-Tech International

TRT

Trio-Tech International

HOLD

Current Price

$5.60

Market Cap

35.1M

Sector

Technology

ML Signal

HOLD

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.15

Market Cap

28.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRT
BCTX
Founded
1958
2014
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.1M
28.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TRT
BCTX
Price
$5.60
$4.15
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
82.3K
1.1M
Earning Date
02-10-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$42,188,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$380.95
P/E Ratio
$163.26
N/A
Revenue Growth
0.10
N/A
52 Week Low
$2.31
$4.10
52 Week High
$7.60
$98.20

Technical Indicators

Market Signals
Indicator
TRT
BCTX
Relative Strength Index (RSI) 29.61 37.79
Support Level $5.25 $4.20
Resistance Level $6.43 $4.50
Average True Range (ATR) 0.43 0.32
MACD -0.03 0.07
Stochastic Oscillator 6.67 9.93

Price Performance

Historical Comparison
TRT
BCTX

About TRT Trio-Tech International

Trio-Tech International operates in the semiconductor industry, providing manufacturing, testing, and distribution services for semiconductor test equipment and electronic components. It has two main segments: Semiconductor Back-end Solutions (SBS) and Industrial Electronics (IE). The SBS segment, which generates the majority of the Company's revenue, focuses on manufacturing equipment for semiconductor back-end processes, offering testing services, and distributing burn-in test related equipment. The IE segment manufactures equipment for other industries and distributes electronic products outside the semiconductor sector. The Company operates in the United States, Singapore, Malaysia, Thailand, and China, serving customers across multiple regions.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: